Efficiency of autologous bone marrow stem cell for ischemic disease of lower extremity in 254 cases

XU Yi-feng,YANG Xiao-feng,WU Yan-xiang,WANG Hong-mei,ZHANG Yi-bin,Lü Nai-wu,SHAN Hong,CUI Ji-ping,ZHOU Jin-xu
DOI: https://doi.org/10.3877/cma.j.issn.2095-1221.2011.02.010
2011-01-01
Abstract:Objective To evaluate the efficiency of autologous bone mononuclear cell(ABMC) transplantation in the treatment of ischemic disease of lower extremity.Methods Treatment records of 254 patients with ischemic disease of lower extremity were retrieved.All patients have been followed up for one year from November 2003 to August 2008.The skin temperature,bathesthesia,transcutaneous partial pressure O2(TcPo2) and ankle-brachial index(ABI) were rechecked at 3,6 and 12 months after transplantation,and the symptoms of pain,cold,intermittent claudication and ulcer and gangrene were evaluated.Results A total of 254 patients were evaluated.(1) Alleviation of pain and cold was reported in 61.8﹪(157/254) and 74﹪(188/254) of the patients respectively.Improvement of claudication was noted in 40.2﹪(102/254);Alleviation of ulcer was noted in 59﹪(36/61).Six patients received amputation due to gangrene,5 patients healed by ablation,8 patients were stable and 7 patients have worsened ischemia.(2)The skin temperature of lower extremity increased from 32.89℃±2.19℃ to 35.52℃±2.26℃(t=13.32,P=0.000),TcPo2 increased from(26.46±18.49) mmHg to(34.14±14.99) mmHg(t=5.157,P=0.000).The ABI increased from(0.62±0.36) to(0.84±0.24)(t=8.104,P=0.000).Conclusion ABMC transplantation is effective in the treatment of ischemic disease of lower extremity.
What problem does this paper attempt to address?